Geoff Saunders

Southampton, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Clinical and cost-effectiveness of a cycling and education intervention versus usual physiotherapy care for the treatment of hip osteoarthritis in the UK (CLEAT): a pragmatic, randomised, controlled trial.

Clinical and cost-effectiveness of a cycling and education intervention versus usual physiotherapy care for the treatment of hip osteoarthritis in the UK (CLEAT): a pragmatic, randomised, controlled trial.

Journal: The Lancet. Rheumatology

Published: January 27, 2025

Including patient and public contributors on clinical trial Independent Data Monitoring Committees (IDMCs).

Including patient and public contributors on clinical trial Independent Data Monitoring Committees (IDMCs).

Journal: Trials

Published: December 20, 2024

Dose escalation of tolinapant (ASTX660) in combination with standard radical chemoradiotherapy in cervical cancer : a study protocol for a phase 1b TiTE-CRM clinical trial (CRAIN) in UK secondary care centres.

Dose escalation of tolinapant (ASTX660) in combination with standard radical chemoradiotherapy in cervical cancer : a study protocol for a phase 1b TiTE-CRM clinical trial (CRAIN) in UK secondary care centres.

Journal: BMC cancer

Published: April 12, 2024

CycLing and EducATion (CLEAT): protocol for a single centre randomised controlled trial of a cycling and education intervention versus standard physiotherapy care for the treatment of hip osteoarthritis.

CycLing and EducATion (CLEAT): protocol for a single centre randomised controlled trial of a cycling and education intervention versus standard physiotherapy care for the treatment of hip osteoarthritis.

Journal: BMC musculoskeletal disorders

Published: April 21, 2023

Differential Efficacy From the Addition of Bortezomib to R-CHOP in Diffuse Large B-Cell Lymphoma According to the Molecular Subgroup in the REMoDL-B Study With a 5-Year Follow-Up.

Differential Efficacy From the Addition of Bortezomib to R-CHOP in Diffuse Large B-Cell Lymphoma According to the Molecular Subgroup in the REMoDL-B Study With a 5-Year Follow-Up.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: March 27, 2023

Practical recommendations for implementing a Bayesian adaptive phase I design during a pandemic.

Practical recommendations for implementing a Bayesian adaptive phase I design during a pandemic.

Journal: BMC medical research methodology

Published: September 03, 2021

Phase I Trial of DNA Methyltransferase Inhibitor Guadecitabine Combined with Cisplatin and Gemcitabine for Solid Malignancies Including Urothelial Carcinoma (SPIRE).

Phase I Trial of DNA Methyltransferase Inhibitor Guadecitabine Combined with Cisplatin and Gemcitabine for Solid Malignancies Including Urothelial Carcinoma (SPIRE).

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: October 12, 2020

Screening tool for malignant bowel obstruction in relapsed, metastatic ovarian cancer.

Screening tool for malignant bowel obstruction in relapsed, metastatic ovarian cancer.

Journal: ESMO open

Published: October 26, 2018

Dose-dense cisplatin with gemcitabine for relapsed platinum-resistant ovarian cancer.

Dose-dense cisplatin with gemcitabine for relapsed platinum-resistant ovarian cancer.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: September 12, 2018

An Outpatient, Dose-Intense, Intravenous Cisplatin and Oral Etoposide Regimen for the Treatment of Advanced, Platinum-Resistant Ovarian Cancer.

An Outpatient, Dose-Intense, Intravenous Cisplatin and Oral Etoposide Regimen for the Treatment of Advanced, Platinum-Resistant Ovarian Cancer.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: February 22, 2018

Showing 1-10 of 10

Last Updated: 09/26/2026